tiprankstipranks
Trending News
More News >
Cyclopharm Limited (AU:CYC)
ASX:CYC
Australian Market

Cyclopharm Limited (CYC) Stock Statistics & Valuation Metrics

Compare
13 Followers

Total Valuation

Cyclopharm Limited has a market cap or net worth of AU$118.92M. The enterprise value is AU$104.41M.
Market CapAU$118.92M
Enterprise ValueAU$104.41M

Share Statistics

Cyclopharm Limited has 111,136,850 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding111,136,850
Owned by Insiders
Owned by Institutions

Financial Efficiency

Cyclopharm Limited’s return on equity (ROE) is -0.31 and return on invested capital (ROIC) is -27.78%.
Return on Equity (ROE)-0.31
Return on Assets (ROA)-0.21
Return on Invested Capital (ROIC)-27.78%
Return on Capital Employed (ROCE)-0.28
Revenue Per Employee290.24K
Profits Per Employee-138.92K
Employee Count95
Asset Turnover0.44
Inventory Turnover0.73

Valuation Ratios

The current PE Ratio of Cyclopharm Limited is -12.39. Cyclopharm Limited’s PEG ratio is 0.26.
PE Ratio-12.39
PS Ratio0.00
PB Ratio2.70
Price to Fair Value3.83
Price to FCF-8.67
Price to Operating Cash Flow-9.17
PEG Ratio0.26

Income Statement

In the last 12 months, Cyclopharm Limited had revenue of 27.57M and earned -13.20M in profits. Earnings per share was -0.13.
Revenue27.57M
Gross Profit17.93M
Operating Income-14.35M
Pretax Income-13.07M
Net Income-13.20M
EBITDA-13.69M
Earnings Per Share (EPS)-0.13

Cash Flow

In the last 12 months, operating cash flow was -12.57M and capital expenditures -880.76K, giving a free cash flow of -13.46M billion.
Operating Cash Flow-12.57M
Free Cash Flow-13.46M
Free Cash Flow per Share-0.12

Dividends & Yields

Cyclopharm Limited pays an annual dividend of AU$0.004, resulting in a dividend yield of ―
Dividend Per ShareAU$0.004
Dividend Yield
Payout RatioN/A
Free Cash Flow Yield
Earnings Yield

Stock Price Statistics

Beta0.30
52-Week Price Change-31.85%
50-Day Moving Average1.17
200-Day Moving Average1.52
Relative Strength Index (RSI)39.58
Average Volume (3m)50.56K

Important Dates

Cyclopharm Limited upcoming earnings date is Sep 2, 2025, TBA Not Confirmed.
Last Earnings DateFeb 24, 2025
Next Earnings DateSep 2, 2025
Ex-Dividend DateSep 01, 2023

Financial Position

Cyclopharm Limited as a current ratio of 3.99, with Debt / Equity ratio of 19.39%
Current Ratio3.99
Quick Ratio2.75
Debt to Market Cap0.00
Net Debt to EBITDA0.90
Interest Coverage Ratio-44.96

Taxes

In the past 12 months, Cyclopharm Limited has paid 126.17K in taxes.
Income Tax126.17K
Effective Tax Rate>-0.01

Enterprise Valuation

Cyclopharm Limited EV to EBITDA ratio is -11.05, with an EV/FCF ratio of -11.17.
EV to Sales5.49
EV to EBITDA-11.05
EV to Free Cash Flow-11.17
EV to Operating Cash Flow-12.03

Balance Sheet

Cyclopharm Limited has AU$20.57M in cash and marketable securities with AU$8.29M in debt, giving a net cash position of -AU$12.28M billion.
Cash & Marketable SecuritiesAU$20.57M
Total DebtAU$8.29M
Net Cash-AU$12.28M
Net Cash Per Share-AU$0.11
Tangible Book Value Per ShareAU$0.36

Margins

Gross margin is 32.10%, with operating margin of -52.03%, and net profit margin of -47.87%.
Gross Margin32.10%
Operating Margin-52.03%
Pretax Margin-47.41%
Net Profit Margin-47.87%
EBITDA Margin-49.65%
EBIT Margin-52.68%

Analyst Forecast

The average price target for Cyclopharm Limited is AU$2.20, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price TargetAU$2.20
Price Target Upside105.61% Upside
Analyst ConsensusModerate Buy
Analyst Count1
Revenue Growth Forecast4.68%
EPS Growth Forecast-155.42%

Scores

Smart Score4
AI Score44
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis